Applied Genetic Technologies (AGTC) 10-K/A2022 FY Annual report (amended)

Content analysis

Filed: 24 Oct 22, 4:15pm

Date: October 24, 2022

/s/ Susan B. Washer

Susan B. Washer

Chief Executive Officer and President

(Principal Executive Officer)

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Abbvie, Abraham, antiviral, appointed, back, Bausch, BioFlorida, BioPharm, biopharma, bioscience, Bombay, Botanic, Cairo, Cantor, Casebia, collateral, compensatory, Danforth, departure, DePaul, Egypt, Eloxx, embedded, Fitzgerald, Formation, formatted, fringe, Garden, Glaucoma, GSK, Hashad, herewith, Inline, IRA, Irvine, Iveric, Ji, Jonathan, Lieber, Loan, Lomb, Magenta, Metamark, Militia, MPA, NV, ObsEva, OfferingSM, oversaw, Oxurion, pandemic, Paragon, phrma, Protego, READDI, Recode, rejoined, Repligen, Robinson, SA, Sanofi, Scaria, Schneider, Spirovant, Stern, thirteen, urologic, Urovant, wife, Xcellerex, Xing, Yehia

Removed: academic, accountant, agreed, agtc, Arnold, began, Binney, Biogen, Bristol, Cambridge, Canadian, career, Centre, collaborate, collaboration, commercialization, commercialize, conducted, Conshohocken, controller, develop, diligence, disclosed, dispose, disposition, dispositive, Dohme, Dougherty, due, Durham, Dyax, earlier, EMD, Germany, Gilbert, Guy, Hall, implementing, increasing, intellectual, interim, InterWest, investor, Ivana, Japan, juvenile, KGaA, Kliman, letter, London, MA, Mark, Menlo, Merck, milestone, million, Mitchell, Mumma, note, Nottingham, occurrence, offer, offered, ophthalmologist, Oronsky, patent, payment, pigmentosa, Plaza, ranging, recorded, reimbursable, reported, responsibility, revenue, Road, RSM, Sand, seek, Serono, share, Sharp, Shearman, Street, subsidiary, Suffolk, targeting, Teva, transfer, Transkaryotic, UAB, vector, VI, ViewPoint, VIII, vote, Washington, wholly, worldwide, XLRP

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

AGTC similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 31.1

CERTIFICATION

I, Susan B. Washer, certify that:

1.	I have reviewed this Amendment No.1 to the Annual Report on Form 10-K of Applied Genetic Technologies Corporation; and

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.